Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00466570 |
Topical ophthalmic antibiotics are common prescribed just prior to eye surgery to lower the risk of infection. Previous studies have suggested that antibiotics containing a preservative (Zymar) kill bacteria much quicker than those without a preservative (Vigamox). The purpose of this research is to compare how quickly to the two commonly prescribed antibiotics eliminate bacteria from the eye surface.
Condition | Intervention |
---|---|
Conjunctical Flora |
Drug: gatifloxacin, moxifloxacin |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study |
Official Title: | Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-Hour |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Miri Englander, BA | 650 804 8408 | MiriMD@Stanford.edu |
United States, California | |
Stanford University | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Christopher Ta, MD 650-723-6995 cta@stanford.edu | |
Contact: Miri Englander, BA 650 804 8408 | |
Principal Investigator: Christopher Ta, MD |
Principal Investigator: | Christopher Ta, MD | Stanford University |
Study ID Numbers: | 8924 |
Study First Received: | April 25, 2007 |
Last Updated: | April 26, 2007 |
ClinicalTrials.gov Identifier: | NCT00466570 History of Changes |
Health Authority: | United States: Institutional Review Board |
Moxifloxacin Gatifloxacin |
Anti-Infective Agents Moxifloxacin Therapeutic Uses Pharmacologic Actions Gatifloxacin |